Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;24(3):193-6.
doi: 10.1007/BF00300242.

A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting

G Falkson  1 , A J van Zyl
Affiliations

A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting

G Falkson et al. Cancer Chemother Pharmacol. 1989.

Abstract

In a phase I study of BRL43694A, a 5HT3-receptor antagonist, a single dose of 40 micrograms/kg was given to 24 patients. All patients received cytostatic treatment expected to cause nausea and vomiting. During the first 24 h, 12 patients were completely protected from nausea and vomiting, 4 experienced nausea and 8 had moderate vomiting; mild headache occurred in 10 patients. No cardiovascular (including ECG) changes took place. Apart from headache, no neurological side effects occurred.

PubMed Disclaimer

References

    1. Cancer Treat Rev. 1987 Dec;14(3-4):333-6 - PubMed
    1. J Clin Oncol. 1988 Apr;6(4):659-62 - PubMed
    1. Br J Pharmacol. 1986 Jul;88(3):497-9 - PubMed
    1. Am J Clin Oncol. 1982 Dec;5(6):649-55 - PubMed

Publication types

MeSH terms

LinkOut - more resources